ong-term observational study for pediatric brain tumors
- Conditions
- Pediatric brain tumorbrain tumorD001932
- Registration Number
- JPRN-jRCT1050220134
- Lead Sponsor
- Fujisaki Hiroyuki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1000
1) Patients with brain tumors younger than 30 years old at diagnosis (histology is not limited).
2) Registration of the JCCG pediatric solid tumor observation study has been completed at the time of participation in this study.
3) Registration for the other prospective interventional study for pediatric brain tumors conducted by JCCG is completed.
3) At the same time as this study, the patient is enrolled or will be enrolled in a prospective clinical study conducted by the JCCG Brain Tumor Committee.
4) Written informed consent from the patient and/or legally acceptable proxy has been obtained.
Patients who are unable to evaluate the late effects.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival rate at 20 years
- Secondary Outcome Measures
Name Time Method Overall survival rates at 5 and 10 years<br>Progression-free survival rate at 5 and 10 years<br>Rate of late complications (Neurocognitive, Endroine, Cardiovascular, Fertility, Stroke, etc)<br>Rate of secondary neoplasms<br>Social outcomes<br>Rate and causes of late mortalities